Data / Drug companies / Nitrofuran Antibacterial
Nitrofuran Antibacterial drugs: 10 drugs from 53 companies in the FDA NDC directory
Nitrofuran Antibacterial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 140 products in this class from 53 companies, covering 10 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 19, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 53Companies
- 140Products
- 10Drugs by generic name
Drugs in the Nitrofuran Antibacterial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Nitrofurantoin | 36 | 28 |
| Nitrofurantoin (monohydrate/macrocrystals) | 41 | 25 |
| Nitrofurantoin macrocrystals | 38 | 20 |
| Nitrofurantion | 10 | 6 |
| Nitrofurantoin monohydrate/macrocrystalline | 5 | 4 |
| Nitrofurantoin (macrocrystals) | 4 | 2 |
| Nitrofurantion macrocrystals | 2 | 2 |
| Nitrofurantoin monohydrate | 2 | 2 |
| Nitrofurantoin monohydrate/macrocrystal | 1 | 1 |
| Nitrofurantoin monohydrate/macrocrystals | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 9 | capsule | Generic drugs (ANDA) | September 14, 2023 |
| Remedyrepack Inc. | 8 | capsule | Generic drugs (ANDA) | June 16, 2025 |
| BluePoint Laboratories | 7 | capsule | Generic drugs (ANDA) | October 15, 2023 |
| A-S Medication Solutions | 6 | capsule | Generic drugs (ANDA) | December 1, 2023 |
| NuCare Pharmaceuticals,Inc. | 6 | capsule | Generic drugs (ANDA) | September 14, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule | Generic drugs (ANDA) | March 21, 2023 |
| Redpharm Drug | 6 | capsule | Generic drugs (ANDA) | December 1, 2023 |
| NorthStar RxLLC | 5 | capsule; suspension | Generic drugs (ANDA) | December 1, 2023 |
| Aurobindo Pharma Limited | 4 | capsule; suspension | Generic drugs (ANDA) | October 2, 2024 |
| Lifestar Pharma LLC | 4 | capsule | Generic drugs (ANDA) | September 14, 2023 |
| Northwind Health Company, LLC | 4 | capsule | Generic drugs (ANDA) | October 16, 2024 |
| Proficient Rx LP | 4 | capsule | Generic drugs (ANDA) | January 1, 2018 |
| Alembic Pharmaceuticals Inc. | 3 | capsule | Generic drugs (ANDA) | July 1, 2021 |
| Alembic Pharmaceuticals Limited | 3 | capsule | Generic drugs (ANDA) | July 1, 2021 |
| Lupin Pharmaceuticals,Inc. | 3 | capsule; suspension | Generic drugs (ANDA) | July 9, 2018 |
| Proficient Rx LP | 3 | capsule | Generic drugs (ANDA) | September 14, 2023 |
| Proficient Rx LP | 3 | capsule | New drug applications (NDA) | May 25, 2011 |
| St. Mary's Medical Park Pharmacy | 3 | capsule | Generic drugs (ANDA) | October 19, 2026 |
| Sun Pharmaceutical Industries, Inc. | 3 | capsule | Generic drugs (ANDA) | April 15, 2016 |
| American Health Packaging | 2 | capsule | Generic drugs (ANDA) | April 28, 2024 |
| Amneal Pharmaceuticals LLC | 2 | suspension; capsule | Generic drugs (ANDA) | May 25, 2017 |
| Amneal Pharmaceuticals of New York LLC | 2 | capsule | Generic drugs (ANDA) | March 8, 2007 |
| Asclemed USA, Inc. | 2 | capsule | Generic drugs (ANDA) | February 22, 2022 |
| AvPAK | 2 | capsule | Generic drugs (ANDA) | December 8, 2017 |
| Bryant Ranch Prepack | 2 | capsule | Generic drugs (ANDA) | January 1, 2018 |
| Bryant Ranch Prepack | 2 | capsule | Generic drugs (ANDA) | March 30, 2023 |
| Coupler LLC | 2 | capsule | Generic drugs (ANDA) | May 7, 2026 |
| Direct RX | 2 | capsule | New drug applications (NDA) | February 7, 2024 |
| Direct_Rx | 2 | capsule | Generic drugs (ANDA) | November 22, 2022 |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | February 22, 2022 |
| Major Pharmaceuticals | 2 | capsule | Generic drugs (ANDA) | April 6, 2026 |
| Preferred Pharmaceuticals Inc. | 2 | capsule | Generic drugs (ANDA) | January 25, 2024 |
| QPharma, Inc. | 2 | capsule | Generic drugs (ANDA) | February 22, 2022 |
| Zydus Lifesciences Limited | 2 | capsule | Generic drugs (ANDA) | February 15, 2018 |
| Zydus Pharmaceuticals USA Inc. | 2 | capsule | Generic drugs (ANDA) | February 15, 2018 |
| Almatica Pharma LLC | 1 | capsule | New drug applications (NDA) | May 31, 2011 |
| Alvogen Inc. | 1 | capsule | New drug applications (NDA) | May 25, 2011 |
| Amneal Pharmaceuticals NY LLC | 1 | suspension | Generic drugs (ANDA) | May 31, 2021 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | April 17, 2023 |
| Aurobindo Pharma Limited | 1 | capsule | Generic drugs (ANDA) | March 30, 2023 |
| Biocon Pharma Inc. | 1 | suspension | Generic drugs (ANDA) | November 15, 2024 |
| Camber Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | July 2, 2025 |
| Creekwood Pharmaceuticals LLC | 1 | capsule | Generic drugs (ANDA) | April 20, 2026 |
| Micro Labs Limited | 1 | capsule | Generic drugs (ANDA) | April 1, 2024 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | capsule | Generic drugs (ANDA) | February 22, 2022 |
| Novel Laboratories, Inc. | 1 | suspension | Generic drugs (ANDA) | September 8, 2014 |
| PharmPak, Inc. | 1 | capsule | New drug applications (NDA) | July 10, 2019 |
| Rising Pharma Holdings, Inc. | 1 | suspension | Authorized generics (NDA) | February 1, 2024 |
| Rising Pharma Holdings, Inc. | 1 | suspension | Generic drugs (ANDA) | May 11, 2023 |
| Sandoz Inc | 1 | capsule | Generic drugs (ANDA) | April 6, 2005 |
| Somerset Therapeutics, LLC | 1 | for suspension | Generic drugs (ANDA) | February 26, 2025 |
| Trigen Laboratories, LLC | 1 | capsule | Generic drugs (ANDA) | January 1, 2018 |
| Verityrx, LLC | 1 | capsule | Generic drugs (ANDA) | March 21, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 128 | 91.4% |
| Suspension | 11 | 7.9% |
| For suspension | 1 | 0.7% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.